Polaryx Therapeutics, Inc. PLYX
1.75 USD -0.05 (-2.78%)
Nov 5, 2026, 11:58 AM EST
1.72 Day range 1.79
1.69 52-week range 48.91
- YTD
- -95.00%
- 1 year
- -95.00%
- Market cap
- 82.85M
- EPS (ttm)
- -0.14
- YTD return
- -95.00%
- 1-year return
- -95.00%
- Volume
- 39.73K
- Avg volume
- 54.06K
- Open
- 1.75
- Previous close
- 1.80
- Day's range
- 1.72 – 1.79
- 52-week range
- 1.69 – 48.91
2Y -33.28 (-95.09%)
Financials — quick view
PLYX Revenue — quarterly 0
PLYX Net income — quarterly -1.38M
PLYX EPS — quarterly -0.03
News
Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket 
Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical Officer 
Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial 
This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday 
Raymond James Initiates Coverage On Polaryx Therapeutics with Strong Buy Rating, Announces Price Target of $6 
12 Health Care Stocks Moving In Friday's Pre-Market Session - LUCID CAPITAL MARKETS Initiates Coverage On Polaryx Therapeutics with Buy Rating, Announces Price Target of $7
HC Wainwright & Co. Initiates Coverage On Polaryx Therapeutics with Buy Rating, Announces Price Target of $7 
12 Health Care Stocks Moving In Tuesday's After-Market Session 
12 Health Care Stocks Moving In Friday's After-Market Session
Your note
Sign in to keep a note on PLYX — it syncs with the Stock Master app.